Literature DB >> 18159460

Epidemiological and economic burden of pneumococcal diseases in Canadian children.

Geneviève Petit1, Philippe De Wals, Barbara Law, Theresa Tam, Lonny James Erickson, Maryse Guay, Alicia Framarin.   

Abstract

BACKGROUND: With the arrival of a new conjugate pneumococcal vaccine, it is important to estimate the burden of pneumococcal diseases in Canadian children. The epidemiological data and the economic cost of these diseases are crucial elements in evaluating the relevance of a vaccination program.
METHODS: Using provincial databases, ad hoc surveys and published data, age-specific incidence rates of pneumococcal infections were estimated in a cohort of 340,000 children between six months and nine years of age. The costs of these diseases to the health system and to families were also evaluated using data from Quebec and Manitoba.
RESULTS: Cumulative risks were one in 5000 for pneumococcal meningitis, one in 500 for bacteremia and one in 20 for pneumonia, leading to 16 deaths in the cohort. About 262,000 otitis media episodes and 32,000 cases of myringotomy with ventilation tube insertion were attributable to Streptococcus pneumoniae. Societal costs were estimated at $125 million, of which 32% was borne by the health system and 68% was borne by families. Invasive infections represented only 2% of total costs, while 84% were generated by otitis media.
CONCLUSION: Pneumococcal infections represent a significant burden for Canadian children and society that could be significantly reduced through immunization.

Entities:  

Keywords:  Canada; Economics; Epidemiology; Pneumococcal infections

Year:  2003        PMID: 18159460      PMCID: PMC2094937          DOI: 10.1155/2003/781794

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  23 in total

1.  Seizures and other neurologic sequelae of bacterial meningitis in children.

Authors:  S L Pomeroy; S J Holmes; P R Dodge; R D Feigin
Journal:  N Engl J Med       Date:  1990-12-13       Impact factor: 91.245

2.  Access to vaccines: A call to action.

Authors:  Noni Macdonald; Joanne Embree
Journal:  Can J Infect Dis       Date:  2003-01

3.  Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988.

Authors:  P B McIntyre; C S Berkey; S M King; U B Schaad; T Kilpi; G Y Kanra; C M Perez
Journal:  JAMA       Date:  1997-09-17       Impact factor: 56.272

4.  Comparative cost analysis of myringotomy with insertion of ventilation tubes in Ontario and British Columbia.

Authors:  P C Coyte; C V Asche; E Ho; T Brassard; J Friedberg
Journal:  J Otolaryngol       Date:  1998-04

5.  Preventing pneumococcal disease among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: 
Journal:  MMWR Recomm Rep       Date:  2000-10-06

6.  Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study.

Authors:  D W Teele; J O Klein; B Rosner
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

7.  Etiology of community-acquired pneumonia in 254 hospitalized children.

Authors:  T Juvén; J Mertsola; M Waris; M Leinonen; O Meurman; M Roivainen; J Eskola; P Saikku; O Ruuskanen
Journal:  Pediatr Infect Dis J       Date:  2000-04       Impact factor: 2.129

8.  Etiology and treatment of community-acquired pneumonia in ambulatory children.

Authors:  L Wubbel; L Muniz; A Ahmed; M Trujillo; C Carubelli; C McCoig; T Abramo; M Leinonen; G H McCracken
Journal:  Pediatr Infect Dis J       Date:  1999-02       Impact factor: 2.129

9.  Population-based, age-specific myringotomy with tympanostomy tube insertion rates in Calgary, Canada.

Authors:  Shalini N Desai; James D Kellner; Derek Drummond
Journal:  Pediatr Infect Dis J       Date:  2002-04       Impact factor: 2.129

10.  The causes of hospital-treated acute lower respiratory tract infection in children.

Authors:  H Nohynek; J Eskola; E Laine; P Halonen; P Ruutu; P Saikku; M Kleemola; M Leinonen
Journal:  Am J Dis Child       Date:  1991-06
View more
  10 in total

1.  Update on acute otitis media in children younger than 2 years of age.

Authors:  Colin J McWilliams; Ran D Goldman
Journal:  Can Fam Physician       Date:  2011-11       Impact factor: 3.275

Review 2.  Cost effectiveness of pneumococcal conjugate vaccination against acute otitis media in children: a review.

Authors:  Chantal W B Boonacker; Pieter H Broos; Elisabeth A M Sanders; Anne G M Schilder; Maroeska M Rovers
Journal:  Pharmacoeconomics       Date:  2011-03       Impact factor: 4.981

3.  Burden of acute otitis media on Canadian families.

Authors:  Eve Dubé; Philippe De Wals; Vladimir Gilca; Nicole Boulianne; Manale Ouakki; France Lavoie; Richard Bradet
Journal:  Can Fam Physician       Date:  2011-01       Impact factor: 3.275

4.  Streptococcus pneumoniae serotype 1 burden in the African meningitis belt: exploration of functionality in specific antibodies.

Authors:  S Blumental; J C Moïsi; L Roalfe; M Zancolli; M Johnson; P Burbidge; R Borrow; S Yaro; J E Mueller; B D Gessner; D Goldblatt
Journal:  Clin Vaccine Immunol       Date:  2015-02-04

5.  The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine.

Authors:  Adrienne Morrow; Philippe De Wals; Geneviève Petit; Maryse Guay; Lonny James Erickson
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-03       Impact factor: 2.471

6.  Pneumococcal conjugate vaccination in Canadian infants and children younger than five years of age: Recommendations and expected benefits.

Authors:  Carol A McClure; Michael W Ford; Jeff B Wilson; Jeff J Aramini
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-01       Impact factor: 2.471

7.  Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada.

Authors:  Stephanie R Earnshaw; Cheryl L McDade; Giovanni Zanotti; Raymond A Farkouh; David Strutton
Journal:  BMC Infect Dis       Date:  2012-04-24       Impact factor: 3.090

8.  The burden of pneumococcal disease in children less than 5 years of age in Abu Dhabi, United Arab Emirates.

Authors:  Mohammad Howidi; Haider Muhsin; Jaishen Rajah
Journal:  Ann Saudi Med       Date:  2011 Jul-Aug       Impact factor: 1.526

9.  Clinical and Economic Impact of a Potential Switch from 13-Valent to 10-Valent Pneumococcal Conjugate Infant Vaccination in Canada.

Authors:  Michele Wilson; Matt Wasserman; Taj Jadavi; Maarten Postma; Marie-Claude Breton; Francois Peloquin; Stephanie Earnshaw; Cheryl McDade; Heather Sings; Raymond Farkouh
Journal:  Infect Dis Ther       Date:  2018-06-22

10.  The cost of illness for childhood clinical pneumonia and invasive pneumococcal disease in Nigeria.

Authors:  Julie Jemutai; Ifedayo M Adetifa; Aishatu Lawal Adamu; Boniface Karia; Musa M Bello; Mahmoud G Jahun; Safiya Gambo; John Ojal; Anthony Scott
Journal:  BMJ Glob Health       Date:  2022-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.